MassClaw is a biotechnology startup developing an AI-driven proteomics platform to standardise fragmented mass spectrometry data, uncover hidden biological signals, and generate actionable insights. The team focuses on accelerating biomarker discovery, drug development, and enabling the scalable translation of research into real-world healthcare and life science applications.
AI proteomics platform standardising mass spectrometry data to uncover hidden biological signals.
Disclaimer: Any opinions, findings, conclusions or recommendations expressed in this material/event (or by members of the project team) do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Innovation and Technology Commission or the General Support Programme Vetting Committee of the Innovation and Technology Fund.
© Designed by WHALE CASTLE IT CONSULTANT, Powered by MAGIC SQUARE STUDIO